10% owner MPM Bioventures 2018 L.P. buys 1,112,777 shares ($20.0M) of AKTS at $18.00 post-IPO; 5 other insiders also bought in 14 days
MPM Bioventures 2018, L.P., a 10% shareholder, deployed $20,029,986.00 to purchase 1,112,777 shares at $18.00 on 2026-01-12, four trading days after AKTS's recent listing. This transaction increased the fund's stake by 12.2% to 10,260,064 shares. The purchase price of $18.00 sits below the current market price of $20.81, establishing a modest unrealized gain on the executed tranche. Notably, this transaction occurs within a cluster pattern: 5 other insiders also bought within the past 14 days, suggesting coordinated confidence from the insider group immediately following the IPO window. The Form 4 contains a derivative-conversion notation; the full economic position may include derivative holdings not yet populated in our database, so the Table I share count alone does not represent the total position. The convergence of post-IPO insider buying across multiple participants is a material signal of support for the IPO valuation.